Federal Register: FDA Issues Notice, Renewal of the Psychopharmacologic Drugs Advisory Committee
May 29, 2026
May 29, 2026
WASHINGTON, May 29 (TNSFR) -- The Food and Drug Administration (FDA) is announcing the renewal of the Psychopharmacologic Drugs Advisory Committee by the Commissioner of Food and Drugs. The Commissioner has determined that it is in the public interest to renew the Psychopharmacologic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the June 4, 2028, expiration date.
SUPPLEMENTARY INFORMATION:
. . .
SUPPLEMENTARY INFORMATION:
. . .